Literature DB >> 31506284

Immunoadsorption and autologous transplantation for life-threatening primary antiphospholipid syndrome.

Anne Angelillo-Scherrer1,2, Behrouz Mansouri Taleghani1, Frauke Förger3, Gabriela M Baerlocher1,2, Thomas Pabst4, Alexander Pöllinger5, Yara Banz6, Thomas Geiser7, Johanna A Kremer Hovinga1,2, Alicia Rovó1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31506284      PMCID： PMC6737408          DOI： 10.1182/bloodadvances.2019000465

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


× No keyword cloud information.
  21 in total

Review 1.  Diffuse alveolar hemorrhage.

Authors:  Abigail R Lara; Marvin I Schwarz
Journal:  Chest       Date:  2010-05       Impact factor: 9.410

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

Review 3.  Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review.

Authors:  Kevin D Deane; Sterling G West
Journal:  Semin Arthritis Rheum       Date:  2005-12       Impact factor: 5.532

4.  Diffuse alveolar hemorrhage and Libman-Sacks endocarditis as a manifestation of possible primary antiphospholipid syndrome.

Authors:  Roodabeh Michelle Koolaee; Anna M Moran; Anupama Shahane
Journal:  J Clin Rheumatol       Date:  2013-03       Impact factor: 3.517

5.  "Possible primary antiphospholipid syndrome" with concurrent diffuse alveolar hemorrhaging and Libman-Sacks endocarditis mimicking catastrophic antiphospholipid syndrome.

Authors:  Akitake Suzuki; Naoki Asazuma; Eigo Kikuchi; Takeshi Kawanobe; Yoshihiko Horimoto; Ryuichi Yokobari; Shigeru Kotake; Takahiro Okai
Journal:  Intern Med       Date:  2012-04-01       Impact factor: 1.271

6.  Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

Authors:  Ricard Cervera; Jean-Charles Piette; Josep Font; Munther A Khamashta; Yehuda Shoenfeld; María Teresa Camps; Soren Jacobsen; Gabriella Lakos; Angela Tincani; Irene Kontopoulou-Griva; Mauro Galeazzi; Pier Luigi Meroni; Ronald H W M Derksen; Philip G de Groot; Erika Gromnica-Ihle; Marta Baleva; Marta Mosca; Stefano Bombardieri; Frédéric Houssiau; Jean-Christophe Gris; Isabelle Quéré; Eric Hachulla; Carlos Vasconcelos; Beate Roch; Antonio Fernández-Nebro; Marie-Claire Boffa; Graham R V Hughes; Miguel Ingelmo
Journal:  Arthritis Rheum       Date:  2002-04

7.  Acute respiratory failure associated with catastrophic antiphospholipid syndrome.

Authors:  F J Wiedermann; A Mayr; W Schobersberger; H Knotzer; N Sepp; M Rieger; W Hasibeder; N Mutz
Journal:  J Intern Med       Date:  2000-06       Impact factor: 8.989

8.  Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation.

Authors:  Laisvyde Statkute; Ann Traynor; Yu Oyama; Kim Yaung; Larissa Verda; Nela Krosnjar; Richard K Burt
Journal:  Blood       Date:  2005-05-03       Impact factor: 22.113

9.  Pulmonary hemorrhage in antiphospholipid antibody syndrome.

Authors:  Anat Scheiman Elazary; Matan J Cohen; Suhail Aamar; Zvi Dranitzki; Oshrat Tayer-Shifman; Dror Mevorach; Eldad Ben-Chetrit; Yaakov Naparstek
Journal:  J Rheumatol       Date:  2012-07-01       Impact factor: 4.666

10.  Fluvastatin inhibits up-regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells.

Authors:  D E Ferrara; R Swerlick; K Casper; P L Meroni; M E Vega-Ostertag; E N Harris; S S Pierangeli
Journal:  J Thromb Haemost       Date:  2004-09       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.